TransCode Therapeutics, Inc. RNAZ
Set alert
1.62 USD -0.01 -0.61%
As of Nov 2, 2:13 PM ET
1.61 Day range 1.69
1.52 52-week range 12.60
- YTD
- -76.28%
- 1 year
- -85.54%
- Open
- 1.69
- Prev close
- 1.63
- Mkt cap
- 27.43M
- Vol
- 12.17K
- Avg vol
- 53.82K
- EPS
- -52.06
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.61
- High
- 1.69
- Forward P/E
- -5.97
- Beta
- 0.65
- Short ratio
- 0.50
- Inst. own
- 1.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 13.50
- 200-d avg
- 20.41
- 1y target
- 20.00
Financial health
Altman Z-Score
-1.94 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
0 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 5
Valuation
P/E -0.1×
FY 2018 5y median -1.4× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.5×
FY 2018 5y median 14.1× FY 2025
P/FCF -0.2×
FY 2018 5y median -1.8× FY 2025
EV/EBITDA 0.4×
FY 2018 5y median -1.2× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -414.4%
FY 2018 5y median -56.8% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -335.4%
FY 2018 5y median -335.4% FY 2025
ROIC -17.6%
FY 2018 5y median -343.4% FY 2025
ROA -21.3%
FY 2018 5y median -229.7% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income -78.7%
FY 2018 FY 2025
EPS (diluted) -11.6%
FY 2018 FY 2025
Free Cash Flow -46.2%
FY 2018 FY 2025
Financial Health
Current Ratio 6.3×
FY 2018 5y median 2.6× FY 2025
Quick Ratio 6.3×
FY 2018 5y median 2.6× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.5×
FY 2018 5y median 0.4× FY 2025
Interest Coverage -4229×
FY 2018 5y median -347× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31